Publicaciones en las que colabora con Jorge Manzanares Robles (8)

2011

  1. Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 105-110

  2. Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 87-95

2005

  1. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies

    Journal of Neural Transmission, Vol. 112, Núm. 4, pp. 557-563

  2. Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain

    Neuropharmacology, Vol. 49, Núm. 5, pp. 618-626

  3. κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice

    European Journal of Neuroscience, Vol. 22, Núm. 8, pp. 2106-2110

2004

  1. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

    Neuropharmacology, Vol. 46, Núm. 7, pp. 966-973

  2. Role of endocannabinoid system in mental diseases

    Neurotoxicity Research, Vol. 6, Núm. 3, pp. 213-224

2002

  1. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies

    Neuroscience Letters, Vol. 333, Núm. 2, pp. 151-153